Ramelteon (Rozerem)
Indications
Prevention of Intensive Care Unit-Associated Delirium (see Delirium, [[Delirium]])
- Clinical Efficacy
- Trial of Ramelteon (Melatonin Agonist) on the Development of Delirium in Elderly (Age 65-89) Hospitalized Patients (JAMA Psychiatry, 2014) [MEDLINE]
- Ramelteon Decreased the Incidence of Delirium
Pharmacology
Metabolism
Administration
Dose Adjustment
Adverse Effects
Other Adverse Effects
References
- Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry. 2014 Apr;71(4):397-403. doi: 10.1001/jamapsychiatry.2013.3320 [MEDLINE]